Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. FYI post-approval change/preclearance exemption/what requires review/PAAB scope
  4. Contextual Use of a Healthcare Product Name
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Contextual Use of a Healthcare Product Name

Scheduled Pinned Locked Moved FYI post-approval change/preclearance exemption/what requires review/PAAB scope
2 Posts 2 Posters 430 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • E Offline
    E Offline
    EY
    wrote on last edited by
    #1

    Regarding Section 1.5 of the PAAB Code – Materials Not Subject to Preclearance, Section D provides examples (i to v) of contextual use of a healthcare product name. Is this an exhaustive list? If we were to have a different example (not represented on the list) where the healthcare product name was used in a context not linked to therapeutic or promotional messages, could it also be considered not subject to preclearance?

    Jennifer CarrollJ 1 Reply Last reply
    0
    • E EY

      Regarding Section 1.5 of the PAAB Code – Materials Not Subject to Preclearance, Section D provides examples (i to v) of contextual use of a healthcare product name. Is this an exhaustive list? If we were to have a different example (not represented on the list) where the healthcare product name was used in a context not linked to therapeutic or promotional messages, could it also be considered not subject to preclearance?

      Jennifer CarrollJ Offline
      Jennifer CarrollJ Offline
      Jennifer Carroll
      wrote on last edited by
      #2

      @eyim

      The types of messages listed in section D are exhaustive. However, it is not exhaustive of how the principles might be demonstrated in a specific APS. We offer our opinion services if a company is unsure if an APS meets exemption criteria.

      Please reach our to our admin team at review@paab.ca should you require assistance with this service.

      1 Reply Last reply
      0
      Reply
      • Reply as topic
      Log in to reply
      • Oldest to Newest
      • Newest to Oldest
      • Most Votes


      • Login

      • Don't have an account? Register

      • Login or register to search.
      • First post
        Last post
      0
      • Categories
      • Recent
      • Tags
      • Popular
      • Users
      • Groups